312 related articles for article (PubMed ID: 12926100)
21. Utility of TL-201 SPECT in clarifying false-positive FDG-PET findings due to osteoradionecrosis in head and neck cancer.
Wang CH; Liang JA; Ding HJ; Yang SN; Yen KY; Sun SS; Kao CH
Head Neck; 2010 Dec; 32(12):1648-54. PubMed ID: 20848403
[TBL] [Abstract][Full Text] [Related]
22.
Han EJ; O JH; Yoo IR; Kim YS; Kim MS; Kang JH; Choi WH
Hell J Nucl Med; 2017; 20(2):134-140. PubMed ID: 28697190
[TBL] [Abstract][Full Text] [Related]
23. Tl-201 SPECT in clarifying false positive FDG PET findings caused by osteoradionecrosis in a case of nasopharyngeal carcinoma.
Wang CH; Liang JA; Yen KY; Hsieh TC; Sun SS; Wu YC; Lin YY; Kao CH
Clin Nucl Med; 2009 Aug; 34(8):515-7. PubMed ID: 19617731
[No Abstract] [Full Text] [Related]
24. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
[TBL] [Abstract][Full Text] [Related]
25. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
Ng SH; Joseph CT; Chan SC; Ko SF; Wang HM; Liao CT; Chang YC; Lin WJ; Fu YK; Yen TC
J Nucl Med; 2004 Oct; 45(10):1669-76. PubMed ID: 15471831
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of undifferentiated carcinoma of nasopharyngeal type with thallium-201 and technetium-99m MIBI SPECT.
Sobic-Saranovic DP; Pendjer IP; Kozarevic NDj; Artiko VM; Mikic AA; Obradovic VB
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):405-11. PubMed ID: 17765766
[TBL] [Abstract][Full Text] [Related]
27. A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden.
Lorberboym M; Baram J; Feibel M; Hercbergs A; Lieberman L
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):249-54. PubMed ID: 7721624
[TBL] [Abstract][Full Text] [Related]
28. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
[TBL] [Abstract][Full Text] [Related]
29. [Clinical value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting recurrent nasopharyngeal carcinoma at the parapharyngeal space after radiotherapy].
Wu DH; Chen LH
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):159-61. PubMed ID: 12581969
[TBL] [Abstract][Full Text] [Related]
30. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.
Chan SC; Ng SH; Chang JT; Lin CY; Chen YC; Chang YC; Hsu CL; Wang HM; Liao CT; Yen TC
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1032-40. PubMed ID: 16622711
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis of recurrent or residual nasopharyngeal carcinomas in the skull base area with F-18-fluoro-deoxyglucose positron emission tomography].
Zeng L; Huang XM; Lu TX; Zheng YQ; Chen QJ; Chen Y; Huang SQ; Sun W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jul; 41(7):517-20. PubMed ID: 17007377
[TBL] [Abstract][Full Text] [Related]
32. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
Thrall MM; DeLoia JA; Gallion H; Avril N
Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284
[TBL] [Abstract][Full Text] [Related]
33. 18F-FDG PET/CT for the Diagnosis of Residual or Recurrent Nasopharyngeal Carcinoma After Radiotherapy: A Metaanalysis.
Zhou H; Shen G; Zhang W; Cai H; Zhou Y; Li L
J Nucl Med; 2016 Mar; 57(3):342-7. PubMed ID: 26541775
[TBL] [Abstract][Full Text] [Related]
34. [Value of 18F-fluorodeoxyglucose positron emission tomography in three-dimensional conformal radiotherapy for locally persistent or recurrent nasopharyngeal carcinoma].
Ding Y; Wu DH; Chen LH
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1568-70. PubMed ID: 16361168
[TBL] [Abstract][Full Text] [Related]
35. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
36. Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.
Yen RF; Sun SS; Shen YY; Changlai SP; Kao A
Anticancer Res; 2001; 21(5):3691-4. PubMed ID: 11848544
[TBL] [Abstract][Full Text] [Related]
37. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
[TBL] [Abstract][Full Text] [Related]
38. Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.
Yen RF; Hong RL; Tzen KY; Pan MH; Chen TH
J Nucl Med; 2005 May; 46(5):770-4. PubMed ID: 15872349
[TBL] [Abstract][Full Text] [Related]
39. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis of recurrent or persistent nasopharyngeal cancers inspite of radiotherapy: Comparison of F-18-deoxyglucose positron emission tomography with computed tomography].
Kuwert T
Strahlenther Onkol; 1999 Aug; 175(8):415. PubMed ID: 10481777
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
